| 2026-08-12 | Press release | PDF Version |
| 2026-08-12 | Press release | NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade G |
| 2026-08-10 | Press release | NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurre |
| 2026-08-10 | Press release | NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout |
| 2026-07-27 | Press release | NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors |
| 2026-07-15 | Press release | NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition |
| 2026-06-23 | Press release | NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data |
| 2026-06-16 | Press release | NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global |
| 2026-05-18 | Press release | NeOnc Provides Business Update and Reports Q1 2026 Financial Results |
| 2026-05-05 | Press release | NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts |
| 2026-04-14 | Press release | NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company P |
| 2026-04-01 | Press release | NeOnc Provides Business Update and Reports Q4 2025 Financial Results |
| 2026-03-04 | Press release | PDF Version |
| 2026-03-04 | Press release | NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phas |
| 2026-02-27 | Press release | PDF Version |
| 2026-02-27 | Press release | NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 |
| 2025-12-15 | Press release | PDF Version |
| 2025-12-15 | Press release | NeOnc Technologies Reports Updated Clinical Results |
| 2025-12-01 | Press release | PDF Version |
| 2025-12-01 | Press release | NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Eff |
| 2025-11-12 | Press release | PDF Version |
| 2025-11-12 | Press release | NeOnc Technologies Reports Updated Clinical Results |
| 2025-11-07 | Press release | PDF Version |
| 2025-11-07 | Press release | NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1 |
| 2025-10-28 | Press release | PDF Version |
| 2025-10-28 | Press release | His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMEN |
| 2025-10-09 | Press release | PDF Version |
| 2025-10-09 | Press release | NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors |
| 2025-10-06 | Press release | PDF Version |
| 2025-10-06 | Press release | NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final |
| 2025-10-02 | Press release | PDF Version |
| 2025-10-02 | Press release | NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Sci |
| 2025-10-01 | Press release | PDF Version |
| 2025-10-01 | Press release | NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumo |
| 2025-09-29 | Press release | PDF Version |
| 2025-09-29 | Press release | NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board |
| 2025-09-10 | Press release | PDF Version |
| 2025-09-10 | Press release | NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral |
| 2025-08-25 | Press release | NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientis |
| 2025-08-11 | Press release | PDF Version |